1. Home
  2. AVAH vs MPLT Comparison

AVAH vs MPLT Comparison

Compare AVAH & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc.

HOLD

Current Price

$9.49

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$36.90

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVAH
MPLT
Founded
1984
2018
Country
United States
United States
Employees
N/A
133
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
AVAH
MPLT
Price
$9.49
$36.90
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$9.75
$32.67
AVG Volume (30 Days)
2.3M
563.2K
Earning Date
05-14-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
1850.00
N/A
EPS
0.19
N/A
Revenue
$2,433,199,000.00
N/A
Revenue This Year
$7.31
N/A
Revenue Next Year
$5.59
N/A
P/E Ratio
$47.79
N/A
Revenue Growth
20.19
N/A
52 Week Low
$3.73
$12.24
52 Week High
$10.32
$40.43

Technical Indicators

Market Signals
Indicator
AVAH
MPLT
Relative Strength Index (RSI) 59.37 54.74
Support Level $8.80 $26.20
Resistance Level $9.86 $40.43
Average True Range (ATR) 0.42 2.75
MACD -0.11 -0.46
Stochastic Oscillator 49.07 35.78

Price Performance

Historical Comparison
AVAH
MPLT

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: